X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Central Nervous System (CNS) Stimulant Drugs Companies

This report lists the top Central Nervous System (CNS) Stimulant Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Central Nervous System (CNS) Stimulant Drugs industry.

Central Nervous System (CNS) Stimulant Drugs Top Companies

  1. Ironshore Pharmaceuticals Inc.

  2. Novartis AG

  3. Takeda Pharmaceutical Co. Ltd

  4. Azurity Pharmaceuticals, Inc.

  5. Noven Therapeutics, LLC.

*Disclaimer: Top companies sorted in no particular order

 Central Nervous System (CNS) Stimulant Drugs Market Major Players

Central Nervous System (CNS) Stimulant Drugs Market Concentration

Central Nervous System (CNS) Stimulant Drugs Market Concentration

Central Nervous System (CNS) Stimulant Drugs Company List

                            • Highland Therapeutics Inc. (Ironshore Pharmaceuticals Inc.)

                            • Hisamitsu Pharmaceutical Co., Inc. (Noven Therapeutics, LLC)

                            • Arbor Pharmaceuticals

                            • Independence Pharmaceuticals

                            • Johnson & Johnson Services, Inc. (Janssen Pharmaceuticals, Inc.)

                            • Novartis AG

                            • Takeda Pharmaceutical Co. Ltd

                            • Elite Pharmaceuticals Inc.

                            • Kempharm, Inc.

                            • Purdue Pharma L.P (Adlon Therapeutics L.P)


                        Specific to Central Nervous System (CNS) Stimulant Drugs Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        Central Nervous System (CNS) Stimulant Drugs Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)